Monitoring prostate cancer using blood tests and imaging techniques
Official title: Integrated radiomic and liquid biopsy monitoring in SWOG S1802: A phase 3 therapeutic trial for metastatic prostate cancer
Funded at University of Southern California · NIH-11015787 · Data updated 2026-11-12
This study is looking at new ways to keep an eye on advanced prostate cancer by using blood tests and special imaging techniques, which could help doctors tailor treatments just for you without needing more invasive procedures.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Southern California NIH-funded |
| Lab location | 1 site (Los Angeles, UNITED STATES) |
| Project start | February 9, 2021 |
| Project end | January 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $689,813 |
| NIH project number | 5R01CA257610-05 |
| Project ID | NIH-11015787 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are men diagnosed with metastatic prostate cancer who are undergoing treatment.
✕Less likely to help
Patients with localized prostate cancer or those not receiving treatment for metastatic disease may not benefit from this research.
What this research studies
This research investigates how to monitor metastatic prostate cancer through two innovative methods: liquid biopsy and radiomic analysis. Liquid biopsy involves analyzing blood samples to detect cancer-related cells and genetic material, while radiomic analysis extracts detailed imaging features from scans. By combining these approaches, the research aims to provide a noninvasive way to track disease progression and response to therapy over time. This could lead to better personalized treatment strategies for patients with advanced prostate cancer.
Why it matters
Potential benefit: If successful, this research could lead to improved monitoring and treatment strategies for men with metastatic prostate cancer.
How similar studies have gone: Previous research has shown promise in using liquid biopsies and radiomic analysis separately, but this integrated approach is relatively novel.
Where this research is happening
-
University of Southern California
Los Angeles, United States Active
Researchers
- Principal investigator: Goldkorn, Amir — University of Southern California
- Study coordinator: Goldkorn, Amir
Related research
Other NIH-funded projects on the same topics.
-
Combination immunotherapy with radioligand therapy for metastatic prostate cancer
A study aims to help men with advanced prostate cancer by combining immune therapy with targeted radiation to boost the body’s own defense against cancer.
-
Understanding what drives lethal metastatic prostate cancer in men
This grant looks at why some prostate cancers become deadly and spread, using patient-derived cells and mouse models.
-
Off-the-shelf tumor cell vaccine tailored to your tumor’s HLA type for advanced prostate cancer
A new vaccine approach uses donor cancer cells matched to a patient’s immune system to help fight advanced prostate cancer.
-
ASH1L’s role in metastatic prostate cancer and its immune environment
Aims to understand how the ASH1L gene helps prostate cancer spread and how it shapes the immune environment in bone metastases so future therapies can target this process.
-
Molecular drivers of lineage changes and new therapies for metastatic prostate cancer
A multi-year study at a major university will explore how metastatic prostate cancer changes its cell type and how to target those changes to help patients.
-
How gut bacteria may affect prostate cancer therapy and resistance
A new study looks at how gut bacteria make compounds that influence prostate cancer treatments and may drive resistance to therapy.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.